Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9845322 | 0.82 | HDAC1 (0.60) | S1PR4KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL4064646 | 0.79 | KMT2A (0.64) | S1PR4KMT2AMEN1CYP1A2CYP2D6 | |
| SCHEMBL9845394 | 0.78 | HCAR3 (0.55) | S1PR4KMT2AMEN1ALDH1A1LMNA | |
| SCHEMBL9522982 | 0.77 | KMT2A (0.58) | RXFP1S1PR4KMT2AMEN1CYP1A2 | |
| SCHEMBL789978 | 0.75 | LMNA (0.64) | LMNASMN1; SMN2 | |
| SCHEMBL9845318 | 0.73 | LCK (0.57) | KMT2A | |
| SCHEMBL9523014 | 0.73 | S1PR4 (0.69) | S1PR4KMT2AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL10473593 | 0.73 | RAB9A (0.62) | KMT2AMEN1ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL4499177 | 0.72 | S1PR4 (0.51) | S1PR4KMT2AMEN1CYP1A2CYP2C9 | |
| SCHEMBL9522743 | 0.72 | S1PR4 (0.58) | S1PR4KMT2AMEN1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0405931-A2 | Improvements in and relating to anticonvulsant agents | ELI LILLY AND COMPANY (US) | 1991-01-02 | — | — | EP | disclosed |